Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.

Ihssen J, Haas J, Kowarik M, Wiesli L, Wacker M, Schwede T, Thöny-Meyer L.

Open Biol. 2015 Apr;5(4):140227. doi: 10.1098/rsob.140227.

2.

The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations.

Kowarik MC, Dzieciatkowska M, Wemlinger S, Ritchie AM, Hemmer B, Owens GP, Bennett JL.

J Neuroinflammation. 2015 Jan 28;12:19. doi: 10.1186/s12974-015-0240-9.

3.

The treatment of neuromyelitis optica.

Kowarik MC, Soltys J, Bennett JL.

J Neuroophthalmol. 2014 Mar;34(1):70-82. doi: 10.1097/WNO.0000000000000102. Review.

4.

Rationally designed short polyisoprenol-linked PglB substrates for engineered polypeptide and protein N-glycosylation.

Liu F, Vijayakrishnan B, Faridmoayer A, Taylor TA, Parsons TB, Bernardes GJ, Kowarik M, Davis BG.

J Am Chem Soc. 2014 Jan 15;136(2):566-9. doi: 10.1021/ja409409h. Epub 2013 Dec 31.

PMID:
24377322
5.

Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli.

Wacker M, Wang L, Kowarik M, Dowd M, Lipowsky G, Faridmoayer A, Shields K, Park S, Alaimo C, Kelley KA, Braun M, Quebatte J, Gambillara V, Carranza P, Steffen M, Lee JC.

J Infect Dis. 2014 May 15;209(10):1551-61. doi: 10.1093/infdis/jit800. Epub 2013 Dec 5.

6.

Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases.

Kowarik MC, Grummel V, Wemlinger S, Buck D, Weber MS, Berthele A, Hemmer B.

J Neurol. 2014 Jan;261(1):130-43. doi: 10.1007/s00415-013-7145-2. Epub 2013 Oct 27.

PMID:
24162037
7.

Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.

Wetter M, Kowarik M, Steffen M, Carranza P, Corradin G, Wacker M.

Glycoconj J. 2013 Jul;30(5):511-22. doi: 10.1007/s10719-012-9451-9. Epub 2012 Oct 6.

PMID:
23053636
8.

Molecular characterization of the viaB locus encoding the biosynthetic machinery for Vi capsule formation in Salmonella Typhi.

Wetter M, Goulding D, Pickard D, Kowarik M, Waechter CJ, Dougan G, Wacker M.

PLoS One. 2012;7(9):e45609. doi: 10.1371/journal.pone.0045609. Epub 2012 Sep 21.

9.

Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB.

Ihssen J, Kowarik M, Wiesli L, Reiss R, Wacker M, Thöny-Meyer L.

BMC Biotechnol. 2012 Sep 24;12:67. doi: 10.1186/1472-6750-12-67.

10.

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.

Kowarik MC, Cepok S, Sellner J, Grummel V, Weber MS, Korn T, Berthele A, Hemmer B.

J Neuroinflammation. 2012 May 16;9:93. doi: 10.1186/1742-2094-9-93.

11.

Severe multiple sclerosis relapse under fingolimod therapy: incident or coincidence?

Castrop F, Kowarik MC, Albrecht H, Krause M, Haslinger B, Zimmer C, Berthele A, Hemmer B.

Neurology. 2012 Mar 20;78(12):928-30. doi: 10.1212/WNL.0b013e31824c46ad. Epub 2012 Mar 7. No abstract available.

PMID:
22402856
12.

Impact of the COMT Val(108/158)Met polymorphism on the mu-opioid receptor system in the human brain: mu-opioid receptor, met-enkephalin and beta-endorphin expression.

Kowarik MC, Einhäuser J, Jochim B, Büttner A, Tölle TR, Riemenschneider M, Platzer S, Berthele A.

Neurosci Lett. 2012 Jan 11;506(2):214-9. doi: 10.1016/j.neulet.2011.11.008. Epub 2011 Nov 10.

PMID:
22101356
13.

Reexpansion pulmonary edema following a posttraumatic pneumothorax: a case report and review of the literature.

Malota M, Kowarik MC, Bechtold B, Kopp R.

World J Emerg Surg. 2011 Sep 2;6:32. doi: 10.1186/1749-7922-6-32.

14.

Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.

Kowarik MC, Pellkofer HL, Cepok S, Korn T, Kümpfel T, Buck D, Hohlfeld R, Berthele A, Hemmer B.

Neurology. 2011 Apr 5;76(14):1214-21. doi: 10.1212/WNL.0b013e3182143564.

PMID:
21464424
15.

Myoclonus-dystonia in 18p deletion syndrome.

Kowarik MC, Langer S, Keri C, Hemmer B, Oexle K, Winkelmann J.

Mov Disord. 2011 Feb 15;26(3):560-1. doi: 10.1002/mds.23446. Epub 2010 Dec 13. No abstract available.

PMID:
21462265
16.

Relaxed acceptor site specificity of bacterial oligosaccharyltransferase in vivo.

Schwarz F, Lizak C, Fan YY, Fleurkens S, Kowarik M, Aebi M.

Glycobiology. 2011 Jan;21(1):45-54. doi: 10.1093/glycob/cwq130. Epub 2010 Sep 16.

17.

Production of glycoprotein vaccines in Escherichia coli.

Ihssen J, Kowarik M, Dilettoso S, Tanner C, Wacker M, Thöny-Meyer L.

Microb Cell Fact. 2010 Aug 11;9:61. doi: 10.1186/1475-2859-9-61.

18.

Platelet-derived growth factor (PDGF) and PDGF receptor expression and function in folliculostellate pituitary cells.

Kowarik M, Onofri C, Colaco T, Stalla GK, Renner U.

Exp Clin Endocrinol Diabetes. 2010 Feb;118(2):113-20. doi: 10.1055/s-0029-1202832. Epub 2009 Apr 16.

PMID:
19373754
19.

NMR structure determination of a segmentally labeled glycoprotein using in vitro glycosylation.

Slynko V, Schubert M, Numao S, Kowarik M, Aebi M, Allain FH.

J Am Chem Soc. 2009 Jan 28;131(3):1274-81. doi: 10.1021/ja808682v.

PMID:
19154179
20.

N-linked glycosylation of folded proteins by the bacterial oligosaccharyltransferase.

Kowarik M, Numao S, Feldman MF, Schulz BL, Callewaert N, Kiermaier E, Catrein I, Aebi M.

Science. 2006 Nov 17;314(5802):1148-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk